IBA Reports Axxion Stake Falls Below 1% Threshold Under Belgian Transparency Law

Ion Beam Applications SA IBA ( (GB:0GZK) ) has issued an update. Ion Beam Applications SA (IBA) reported a transparency notification after investment firm Axxion S.A. reduced its holding in the company below the 1% threshold, as required under Belgian disclosure rules. The threshold was crossed on 27 August 2026, with Axxion's total position, including voting rights and equivalent financial instruments, amounting to 0.97% of IBA's voting rights. The disclosure, made under Belgium's transparency law on significant shareholdings, reflects routine changes in IBA's shareholder structure rather than a shift in control, as Axxion is not a controlled entity. While the stake reduction is modest in size, it offers investors updated visibility on IBA's ownership profile, a factor often monitored by stakeholders in a listed company operating in a specialized healthcare technology niche. The most recent analyst rating on (GB:0GZK) stock is a Hold with a EUR12.00 price target. To see the full list of analyst forecasts on Ion Beam Applications SA IBA stock, see the GB:0GZK Stock Forecast page. More about Ion Beam Applications SA IBA Ion Beam Applications SA (IBA) is a Belgian-based global leader in particle accelerator technology, specializing in proton therapy solutions for cancer treatment, industrial sterilization, radiopharmaceuticals and dosimetry. Listed on Euronext and employing around 2,300 people worldwide, IBA operates as a certified B Corporation, underscoring its commitment to high social and environmental performance standards. The company's market focus centers on advanced radiotherapy equipment and services, positioning it as a key supplier to hospitals, industrial users and nuclear medicine providers. Its leadership in proton therapy, regarded as one of the most advanced forms of radiotherapy, gives IBA a strong strategic role in the growing oncology technology sector. Average Trading Volume: 28,640 Current Market Cap: €465.1M See more insights into 0GZK stock on TipRanks' Stock Analysis page. This story was written using TipRanks's AI tools and reviewed by a TipRanks editor. Disclaimer & DisclosureReport an Issue